Study identifier: NCT05668871 Synced from ClinicalTrials.gov · August 05, 2026
● Completed

A Study of Danning Tablet in Patients With Polypoid Lesions of Gallbladder

Condition: Multiple Gallbladder Polyps  ·  Sponsor: Eastern Hepatobiliary Surgery Hospital

PhasePhase 4
Planned participants326
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The primary aim of this study is to evaluate the efficacy and safety of Danning Tablets in the treatment of MGPs. Specifically, the study seeks to determine whether Danning Tablets, when used alongside standard care, can effectively reduce the size of MGPs and improve related symptoms.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (19)

Hebei general hospitalShijiazhuang, Hebei, China
Tangshan Central HospitalTangshan, Hebei, China
Ezhou Central HospitalEzhou, Hubei, China
Xiantao First People's HospitalXiantao, Hubei, China
Xiangya Changde HospitalChangde, Hunan, China
The First Affiliated Hospital of University of South ChinaHengyang, Hunan, China
Loudi Central HospitalLoudi, Hunan, China
People's Hospital of YiyangYiyang, Hunan, China
Shangrao People's HospitalShangrao, Jiangxi, China
Central Hospital Affiliated to Shandong First Medical University (Jinan Central Hospital)Jinan, Shandong, China
Eastern Hepatobiliary Surgery Hospital, Naval Medical University,Shanghai, Shanghai Municipality, China
Shanxi Traditional Chinese Medicine HospitalTaiyuan, Shanxi, China

+ 7 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →